Literature DB >> 5952885

Burkitt's tumour in England. A comparison with childhood lymphosarcoma.

D H Wright.   

Abstract

Entities:  

Mesh：

Year:  1966        PMID： 5952885     DOI： 10.1002/ijc.2910010510

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  8 in total

Review 1.  Tumours of the lymphoreticular system: nomenclature, histogenesis, and behaviour.

Authors:  N F Gowing
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

2.  [Studies of a Burkitt lymphoma].

Authors:  W M Gallmeier; F W Göbel; W Hartung; C G Schmidt
Journal:  Klin Wochenschr       Date:  1970-05-01

3.  Malignant disease of infancy and childhood with special reference to leukaemia: a survey of 6431 autopsy cases.

Authors:  R Zaldívar
Journal:  Eur J Pediatr       Date:  1976-05-04       Impact factor: 3.183

4.  Burkitt's lymphoma in British adults: clinical features and response to chemotherapy.

Authors:  R L Brearley; T A Lister; J M Whitehouse; A G Stansfeld
Journal:  Br J Cancer       Date:  1977-04       Impact factor: 7.640

5.  Immunophenotypic analysis of childhood Burkitt's lymphoma in the West Midlands 1957-1986.

Authors:  T J Jones; N A Coad; K R Muir; S E Parkes; C D Evans; J R Mann
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

6.  Denis Burkitt and the African lymphoma.

Authors:  I Magrath
Journal:  Ecancermedicalscience       Date:  2009-09-30

7.  Case-control study of paternal occupational exposures and childhood lymphoma in Great Britain, 1962-2010.

Authors:  Kathryn J Bunch; Gerald M Kendall; Charles A Stiller; Timothy J Vincent; Michael F G Murphy
Journal:  Br J Cancer       Date:  2019-05-20       Impact factor: 7.640

8.  Burkitt-type lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian children.

Authors:  T Philip; G M Lenoir; P A Bryon; R Gerard-Marchant; G Souillet; N Philippe; F Freycon; M Brunat-Mentigny
Journal:  Br J Cancer       Date:  1982-05       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.